<p>尽管基准指数开盘走低，但在整个交易过程中表现不佳，最终收盘下跌。</p>
<p>印度股市基准指数，Sensex 和 Nifty50，周二以负面偏向平盘收盘，尽管公营银行、金属和汽车板块强劲买入，但 IT、快速消费品、房地产和制药股的抛售抵消了这些买入。</p>
<p>在收盘时，BSE Sensex 下跌了 20 点。</p>
<p>与此同时，NSE Nifty 下跌了 3 点。</p>
<p>塔塔钢铁、马恒达和巴贾杰金融是今天的主要涨幅股。</p>
<p>而 Infosys、Eternal 和 HCL Tech 则是今天的主要跌幅股。</p>
<p>GIFT Nifty 在撰写时交易于 26,112，上涨 146 点。</p>
<p>BSE 中型股指数下跌 0.1%，BSE 小型股指数下跌 0.2%。</p>
<p>行业指数今天表现混合，医疗保健和房地产板块的股票面临抛售压力。与此同时，金属和汽车板块的股票则出现买入。</p>
<p>卢比对美元的汇率为 89.9 卢比。</p>
<p>MCX 最新合约的黄金价格上涨 1%，每克为 136,274 卢比。</p>
<p>与此同时，白银价格上涨 5%，每公斤为 235,670 卢比。</p>
<h3><strong>Mangalam Shares Jump After Kedia Stake</strong></h3>
<p>在制药行业的新闻中，Mangalam Drugs and Organics 的股票受到关注，因为 Kedia Securities 在该公司购买了股份。</p>
<p>NSE 大宗交易数据显示，由资深投资者 Vijay Kedia 领导的 Kedia Securities 以每股 24.15 卢比购买了 137,794 股 Mangalam Drugs and Organics。根据 BSE 股东结构，截至 2025 年 12 月，管理层持有该公司 50.36% 的股份。</p>
<p>Kedia Securities 是 Vijay Kedia 的投资公司。它投资于在印度证券交易所交易的上市公司和未上市企业，如初创公司。该公司还在房地产领域有投资。</p>
<p>Mangalam Drugs and Organics 拥有近 50 年的经验，在全球范围内以生产关键的抗疟疾活性药物成分（API）而闻名。随着时间的推移，它扩展到多种产品，受益于强大的规模和运营效率。该公司是亚洲多个产品的领先生产商，也是其中一些产品的全球最大制造商。</p>
<h3><strong>Biocon Tie-Up Boosts Ajanta Pharma Shares</strong></h3>
<p>继续关注制药行业的新闻，Ajanta Pharma 的股票受到关注，因为它与 Biocon 签署了战略合作伙伴关系，以为 23 个目标国家采购 semaglutide，并在非洲、中东和中亚拥有半独占权，这标志着在这些市场引入新疗法的重要一步。</p>
<p>该公司表示，在某些市场中，它一直是使用强大现场团队的先驱。这一合作将帮助 Ajanta Pharma 增加其 semaglutide 的市场份额。</p>
<p>在印度，该交易将允许 Ajanta 利用其成熟的销售网络、广泛的医生联系和在慢性治疗领域的强大存在，销售某些 Biocon 产品。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.eqimg.com/images/2025/12302025-chart9-equitymaster.gif?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="755" height="352" original-src="https://imageproxy.pbkrs.com/https://www.eqimg.com/images/2025/12302025-chart9-equitymaster.gif"/></p>
<h3><strong>Defence Digital Win Boosts Silver Touch</strong></h3>
<p>继续关注 IT 行业的新闻，Silver Touch Technologies 的股票受到关注，因为该公司被选为印度海军在 IPADSV2 计划下的数字转型合作伙伴。</p>
<p>这一发展对公司来说是积极的，因为它增强了其国防业务，并预计在未来几年提供稳定的收入和订单增长。</p>
<p>作为项目的一部分，Silver Touch 将为印度海军建立一个数字平台，以提高自动化、效率和安全操作。该平台将帮助管理人员记录、请假和旅行批准、资产和库存，并提供实时报告和仪表板。它还将与其他海军系统连接，确保基于角色的安全访问，并维护适当的文档记录和审计轨迹。</p>
<p>该基于云的、移动友好的系统将支持关键的海军操作，同时提高长期效率和可扩展性。</p>
<p>Silver Touch Technologies 是一家快速增长的 IT 服务公司，提供技术、咨询和业务流程解决方案。它利用先进的技术，如人工智能、自动化、云计算和分析，帮助组织在数字时代实现现代化和成功。</p>
<hr/>
<p><em>更多来自此作者的内容：</em></p>
<p>Nifty 低于 25,950；塔塔钢铁和巴贾杰金融是主要跌幅股</p>
<p>Sensex 今天下跌 345 点；Nifty 低于 25,950</p>
<p>Sensex 今天平盘交易；Nifty 低于 26,100</p>

印孚瑟斯技术

<p>印度股市基准指数 Sensex 和 Nifty50 以负面偏向收盘，受到 IT、快速消费品、房地产和制药行业抛售的影响，尽管公营银行、金属和汽车行业有所上涨。Infosys、Eternal 和 HCL Tech 是主要的跌幅股，而塔塔钢铁和马恒达则有所上涨。印度卢比对美元汇率为 89.9。在制药行业，Mangalam Drugs 被 Kedia Securities 收购了股份，Ajanta Pharma 与 Biocon 合作进行 semaglutide 的分销。Silver Touch Technologies 被选为印度海军的数字合作伙伴，增强了其国防业务</p>

<p>Although the benchmark indices opened lower, they traded negatively throughout the session and ultimately closed in red.</p>
<div class="lb-trans"><p>尽管基准指数开盘走低，但在整个交易过程中表现不佳，最终收盘下跌。</p>
</div><p>Indian equity benchmarks, Sensex and Nifty50, ended flat with a negative bias on Tuesday, as strong buying in PSU bank, metal and auto counters was offset by selling in IT, FMCG, realty and pharma shares.</p>
<div class="lb-trans"><p>印度股市基准指数，Sensex 和 Nifty50，周二以负面偏向平盘收盘，尽管公营银行、金属和汽车板块强劲买入，但 IT、快速消费品、房地产和制药股的抛售抵消了这些买入。</p>
</div><p>At the closing bell, the BSE Sensex closed lower by 20 points.</p>
<div class="lb-trans"><p>在收盘时，BSE Sensex 下跌了 20 点。</p>
</div><p>Meanwhile, the NSE Nifty closed 3 points lower.</p>
<div class="lb-trans"><p>与此同时，NSE Nifty 下跌了 3 点。</p>
</div><p>Tata Steel, M&amp;M, and Bajaj Finserv are among the top gainers today.</p>
<div class="lb-trans"><p>塔塔钢铁、马恒达和巴贾杰金融是今天的主要涨幅股。</p>
</div><p>Infosys, Eternal, HCL Tech, on the other hand, were among the top losers today.</p>
<div class="lb-trans"><p>而 Infosys、Eternal 和 HCL Tech 则是今天的主要跌幅股。</p>
</div><p>The GIFT Nifty was trading at 26,112, higher by 146 points at the time of writing.</p>
<div class="lb-trans"><p>GIFT Nifty 在撰写时交易于 26,112，上涨 146 点。</p>
</div><p>The BSE MidCap index ended 0.1% lower, and the BSE SmallCap index ended 0.2% lower.</p>
<div class="lb-trans"><p>BSE 中型股指数下跌 0.1%，BSE 小型股指数下跌 0.2%。</p>
</div><p>Sectoral indices are trading mixed today, with stocks in the healthcare sector and realty sector witnessing selling pressure. Meanwhile, shares in the metal and auto sectors witnessed buying.</p>
<div class="lb-trans"><p>行业指数今天表现混合，医疗保健和房地产板块的股票面临抛售压力。与此同时，金属和汽车板块的股票则出现买入。</p>
</div><p>The rupee is trading at Rs 89.9 against the US$.</p>
<div class="lb-trans"><p>卢比对美元的汇率为 89.9 卢比。</p>
</div><p>Gold prices for the latest contract on MCX are trading 1% higher at Rs 136,274 per gram.</p>
<div class="lb-trans"><p>MCX 最新合约的黄金价格上涨 1%，每克为 136,274 卢比。</p>
</div><p>Meanwhile, silver prices were trading 5% higher at Rs 235,670 per 1 kg.</p>
<div class="lb-trans"><p>与此同时，白银价格上涨 5%，每公斤为 235,670 卢比。</p>
</div><h3><strong>Mangalam Shares Jump After Kedia Stake</strong></h3>
<div class="lb-trans"><h3><strong>Mangalam Shares Jump After Kedia Stake</strong></h3>
</div><p>In the news from pharma sector, shares of Mangalam Drugs and Organics came into focus after Kedia Securities bought a stake in the company.</p>
<div class="lb-trans"><p>在制药行业的新闻中，Mangalam Drugs and Organics 的股票受到关注，因为 Kedia Securities 在该公司购买了股份。</p>
</div><p>NSE bulk deal data showed that Kedia Securities, led by veteran investor Vijay Kedia, bought 1,37,794 shares of Mangalam Drugs and Organics at Rs 24.15 per share. As per the BSE shareholding pattern, promoters held a 50.36% stake in the company as of December 2025.</p>
<div class="lb-trans"><p>NSE 大宗交易数据显示，由资深投资者 Vijay Kedia 领导的 Kedia Securities 以每股 24.15 卢比购买了 137,794 股 Mangalam Drugs and Organics。根据 BSE 股东结构，截至 2025 年 12 月，管理层持有该公司 50.36% 的股份。</p>
</div><p>Kedia Securities is Vijay Kedia's investment firm. It invests in both listed companies traded on Indian stock exchanges and unlisted businesses such as startups. The firm also has investments in real estate.</p>
<div class="lb-trans"><p>Kedia Securities 是 Vijay Kedia 的投资公司。它投资于在印度证券交易所交易的上市公司和未上市企业，如初创公司。该公司还在房地产领域有投资。</p>
</div><p>Mangalam Drugs and Organics has nearly 50 years of experience and is well known globally for manufacturing key anti-malaria active pharmaceutical ingredients (APIs). Over time, it has expanded into a wide range of products, benefiting from strong scale and operational efficiency. The company is among the leading producers in Asia for several of its products and is the world's largest manufacturer of some of them.</p>
<div class="lb-trans"><p>Mangalam Drugs and Organics 拥有近 50 年的经验，在全球范围内以生产关键的抗疟疾活性药物成分（API）而闻名。随着时间的推移，它扩展到多种产品，受益于强大的规模和运营效率。该公司是亚洲多个产品的领先生产商，也是其中一些产品的全球最大制造商。</p>
</div><h3><strong>Biocon Tie-Up Boosts Ajanta Pharma Shares</strong></h3>
<div class="lb-trans"><h3><strong>Biocon Tie-Up Boosts Ajanta Pharma Shares</strong></h3>
</div><p>Moving on to the news from pharma sector, shares of Ajanta Pharma came into focus after it entered a strategic partnership with Biocon to source semaglutide for 23 target countries, and semi-exclusive rights in Africa, the Middle East, and Central Asia, marking a meaningful step toward introducing newer therapies in these markets.</p>
<div class="lb-trans"><p>继续关注制药行业的新闻，Ajanta Pharma 的股票受到关注，因为它与 Biocon 签署了战略合作伙伴关系，以为 23 个目标国家采购 semaglutide，并在非洲、中东和中亚拥有半独占权，这标志着在这些市场引入新疗法的重要一步。</p>
</div><p>The company said it has been a pioneer in using a strong field force in some markets. This partnership will help Ajanta Pharma increase its market share for semaglutide.</p>
<div class="lb-trans"><p>该公司表示，在某些市场中，它一直是使用强大现场团队的先驱。这一合作将帮助 Ajanta Pharma 增加其 semaglutide 的市场份额。</p>
</div><p>In India, the deal will allow Ajanta to sell certain Biocon products by using its well-established sales network, wide doctor connections, and strong presence in chronic therapy segments.</p>
<div class="lb-trans"><p>在印度，该交易将允许 Ajanta 利用其成熟的销售网络、广泛的医生联系和在慢性治疗领域的强大存在，销售某些 Biocon 产品。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.eqimg.com/images/2025/12302025-chart9-equitymaster.gif" alt="" original-src="https://www.eqimg.com/images/2025/12302025-chart9-equitymaster.gif"/></p>
<h3><strong>Defence Digital Win Boosts Silver Touch</strong></h3>
<div class="lb-trans"><h3><strong>Defence Digital Win Boosts Silver Touch</strong></h3>
</div><p>Moving on to the news from IT sector, shares of Silver Touch Technologies came into focus after the company was chosen as the Digital Transformation Partner for the Indian Navy under the IPADSV2 initiative.</p>
<div class="lb-trans"><p>继续关注 IT 行业的新闻，Silver Touch Technologies 的股票受到关注，因为该公司被选为印度海军在 IPADSV2 计划下的数字转型合作伙伴。</p>
</div><p>This development is positive for the company as it strengthens its defence business and is expected to provide steady revenue and order growth over the coming years.</p>
<div class="lb-trans"><p>这一发展对公司来说是积极的，因为它增强了其国防业务，并预计在未来几年提供稳定的收入和订单增长。</p>
</div><p>As part of the project, Silver Touch will build a digital platform for the Indian Navy to improve automation, efficiency, and secure operations. The platform will help manage personnel records, leave and travel approvals, assets and inventory, and provide real-time reports and dashboards. It will also connect with other Navy systems, ensure secure access based on roles, and maintain proper document records and audit trails.</p>
<div class="lb-trans"><p>作为项目的一部分，Silver Touch 将为印度海军建立一个数字平台，以提高自动化、效率和安全操作。该平台将帮助管理人员记录、请假和旅行批准、资产和库存，并提供实时报告和仪表板。它还将与其他海军系统连接，确保基于角色的安全访问，并维护适当的文档记录和审计轨迹。</p>
</div><p>The cloud-based and mobile-friendly system will support critical Navy operations while improving long-term efficiency and scalability.</p>
<div class="lb-trans"><p>该基于云的、移动友好的系统将支持关键的海军操作，同时提高长期效率和可扩展性。</p>
</div><p>Silver Touch Technologies is a fast-growing IT services company that provides technology, consulting, and business process solutions. It uses advanced technologies such as AI, automation, cloud, and analytics to help organizations modernize and succeed in the digital age.</p>
<div class="lb-trans"><p>Silver Touch Technologies 是一家快速增长的 IT 服务公司，提供技术、咨询和业务流程解决方案。它利用先进的技术，如人工智能、自动化、云计算和分析，帮助组织在数字时代实现现代化和成功。</p>
</div><hr/>
<div class="lb-trans"><hr/>
</div><p><em>More By This Author:</em></p>
<div class="lb-trans"><p><em>更多来自此作者的内容：</em></p>
</div><p>Nifty Below 25,950; Tata Steel &amp; Bajaj Finance Top Losers</p>
<div class="lb-trans"><p>Nifty 低于 25,950；塔塔钢铁和巴贾杰金融是主要跌幅股</p>
</div><p>Sensex Today Ends 345 Points Lower; Nifty Below 25,950</p>
<div class="lb-trans"><p>Sensex 今天下跌 345 点；Nifty 低于 25,950</p>
</div><p>Sensex Today Trades Flat; Nifty Below 26,100</p>
<div class="lb-trans"><p>Sensex 今天平盘交易；Nifty 低于 26,100</p>
</div>

Nifty 指数跌破 25,950 点；印孚瑟斯及内部主要亏损者